Landmark Lipid-Lowering Trials in the Primary Prevention of Cardiovascular Disease-Reference-Cited by-同舟云学术

Landmark Lipid-Lowering Trials in the Primary Prevention of Cardiovascular Disease

Published:2013-05-30 Issue:9 Volume:36 Page:516-523
ISSN:0160-9289
Container-title:Clinical Cardiology
language:en
Short-container-title:Clin Cardiol

Author:

Chrispin Jonathan¹,Martin Seth S.¹,Hasan Rani K.¹,Joshi Parag H.¹,Minder C. Michael¹,McEvoy John W.¹,Kohli Payal²,Johnson Amber E.¹,Wang Libin¹,Blaha Michael J.¹,Blumenthal Roger S.¹

Affiliation:

1. The Johns Hopkins Ciccarone Center for the Prevention of Heart Disease; Johns Hopkins School of Medicine; Baltimore; Maryland

2. Cardiology Division; University of California San Francisco; San Francisco; California.

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/clc.22147/fullpdf

Reference53 articles.

1. Mendis S Puska P Norrving B World Health Organization Global Atlas on Cardiovascular Disease Prevention and Control: Policies, Strategies, and Interventions Geneva 2011

2. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study;Yusuf;Lancet.,2004

3. Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III);Expert Panel on Detection;JAMA,2001

4. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000;Ford;N Engl J Med.,2007

5. Association of temporal trends in risk factors and treatment uptake with coronary heart disease mortality, 1994-2005;Wijeysundera;JAMA.,2010

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. LXR/CD38 activation drives cholesterol-induced macrophage senescence and neurodegeneration via NAD+ depletion;Cell Reports;2024-05

2. L. barbarum (Lycium barbarum L.) supplementation for lipid profiles in adults: A systematic review and meta-analysis of RCTs;Medicine;2023-09-29

3. Cardiovascular risk management in people with type 1 diabetes: performance using three guidelines;BMJ Open Diabetes Research & Care;2022-07

4. Analysis of Coronary Artery Lesion Degree and Related Risk Factors in Patients with Coronary Heart Disease Based on Computer-Aided Diagnosis of Coronary Angiography;Computational and Mathematical Methods in Medicine;2021-12-14

5. Recent advances and emerging therapies in management of dyslipidemias;Trends in Cardiovascular Medicine;2021-10